A 10-year-old girl named Ke Ke (alias) was given the first dose of China-produced bivalent human papillomavirus (HPV) vaccine at Hubei Maternity and Child Health Hospital on Monday.

Peng Min and her daughter Ke Ke register for vaccination. (Photos: Wuhan Evening News)

The girl’s mother Peng Min, an obstetrician at the Maternity and Child Health Hospital in Hubei Province, was also a recipient of the vaccine. Before Peng decided to vaccinate herself and her daughter against cervical cancer, she carefully studied the differences between bivalent, quadrivalent and nonavalent vaccines, as well as information about imported and domestic vaccines.

Ke Ke gets vaccination.

Cervical cancer is one of the most common cancers in Hubei Province, whose morbidity and mortality rank first. In recent years, cervical cancer has shown a younger trend. The incidence rate of cervical cancer ranks second among women aged 15 to 44 in China. The outbreak of cervical cancer is associated with persistent HPV (human papillomavirus) infection. There are two peak ranges in the age of HPV infection in Chinese women: 15 to 24 years old and 40 to 44 years old.

(Compiled by Hai Han)